AU2022399234A1 - Analogues of mdma for modulating sert, dat, and / or net activity - Google Patents
Analogues of mdma for modulating sert, dat, and / or net activity Download PDFInfo
- Publication number
- AU2022399234A1 AU2022399234A1 AU2022399234A AU2022399234A AU2022399234A1 AU 2022399234 A1 AU2022399234 A1 AU 2022399234A1 AU 2022399234 A AU2022399234 A AU 2022399234A AU 2022399234 A AU2022399234 A AU 2022399234A AU 2022399234 A1 AU2022399234 A1 AU 2022399234A1
- Authority
- AU
- Australia
- Prior art keywords
- disorder
- alkenyl
- haloalkenyl
- alkyl
- haloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021903836 | 2021-11-26 | ||
| AU2021903836A AU2021903836A0 (en) | 2021-11-26 | Analogues | |
| AU2022901261 | 2022-05-12 | ||
| AU2022901261A AU2022901261A0 (en) | 2022-05-12 | Analogues | |
| PCT/AU2022/051422 WO2023092195A1 (en) | 2021-11-26 | 2022-11-28 | Analogues of mdma for modulating sert, dat, and / or net activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2022399234A1 true AU2022399234A1 (en) | 2024-05-23 |
Family
ID=86538463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022399234A Pending AU2022399234A1 (en) | 2021-11-26 | 2022-11-28 | Analogues of mdma for modulating sert, dat, and / or net activity |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4436964A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024544586A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022399234A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3239040A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023092195A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3519816A4 (en) | 2016-09-29 | 2020-05-06 | The Regents of the University of California | CONNECTIONS FOR INCREASING NEURONAL PLASTICITY |
| KR102946120B1 (ko) | 2019-02-27 | 2026-03-30 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클 |
| WO2022221415A2 (en) | 2021-04-13 | 2022-10-20 | The Regents Of The University Of California | Tetracyclic compounds for treating brain disorders |
| JP2025502615A (ja) | 2021-12-15 | 2025-01-28 | デリックス セラピューティクス,インク. | フェノキシおよびベンジルオキシ置換サイコプラストゲンならびにその使用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005154350A (ja) * | 2003-11-26 | 2005-06-16 | Japan Science & Technology Agency | 不斉アリルアミンの合成方法 |
| AU2004309067B2 (en) * | 2003-12-23 | 2009-12-17 | Basf Aktiengesellschaft | 1-(azolin-2-yl) amino-1,2-diphenylethane compounds for combatting insects, arachnids and nematodes |
-
2022
- 2022-11-28 JP JP2024529704A patent/JP2024544586A/ja active Pending
- 2022-11-28 WO PCT/AU2022/051422 patent/WO2023092195A1/en not_active Ceased
- 2022-11-28 EP EP22896885.5A patent/EP4436964A4/en active Pending
- 2022-11-28 AU AU2022399234A patent/AU2022399234A1/en active Pending
- 2022-11-28 CA CA3239040A patent/CA3239040A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3239040A1 (en) | 2023-06-01 |
| WO2023092195A1 (en) | 2023-06-01 |
| EP4436964A4 (en) | 2025-10-08 |
| EP4436964A1 (en) | 2024-10-02 |
| JP2024544586A (ja) | 2024-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4436964A1 (en) | Analogues of mdma for modulating sert, dat, and / or net activity | |
| KR20220137083A (ko) | Cns 장애의 치료를 위한 세로토닌성 사이키델릭 작용제로서의 실로신 유도체 | |
| JP7036725B2 (ja) | Kv3チャネルのヒダントインモジュレーター | |
| AU2002237654B2 (en) | Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders | |
| JP6751161B2 (ja) | フッ素含有トリアゾロピリジン系化合物、その製造方法、医薬組成物及び用途 | |
| CN108137508B (zh) | 5-ht2c受体激动剂和组合物及使用方法 | |
| JP2010508343A (ja) | 薬理学的に活性なn,n’−置換型3,7−ジアザビシクロ[3.3.1]ノナン類、それらに基づく医薬組成物、及びそれらの使用方法 | |
| CN109715613A (zh) | 杂环化合物 | |
| HRP940890A2 (en) | Novel(r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benozpyranes | |
| TW200911254A (en) | Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators-842 | |
| CN104995182A (zh) | 被取代的喹喔啉衍生物及其作为mGluR4的正变构调节剂的用途 | |
| CN117242065A (zh) | 作为血清素能药物的用于治疗与之相关的疾病的吲哚衍生物 | |
| CN109952301A (zh) | 5-ht2c受体激动剂和组合物及使用方法 | |
| HUE034656T2 (hu) | (S)-(2-(6-Klór-7-metil-1H-benzo[d]imidazol-2-il)-2-metilpirrolidin-1-il)(5-metoxi-2-(2H-1,2,3-triazol-2-il) fenil)metanon kristályos sóformája mint orexin receptor antagonista | |
| JP5744203B2 (ja) | オレキシン受容体拮抗薬としてのプロリンスルフォンアミド誘導体 | |
| CA2988861A1 (en) | 5-aromatic alkynyl substituted benzamide compound and preparation method, pharmaceutical composition, and use thereof | |
| JP6483105B2 (ja) | ピペラジン誘導体および医薬としてのその使用 | |
| CN104955826A (zh) | 可用于治疗神经学疾病和病症的螺-喹唑酮衍生物 | |
| JP6378404B2 (ja) | 新規化合物 | |
| JP2011506551A (ja) | Ampa受容体増強化合物および医薬におけるその使用 | |
| Oberdorf et al. | Thiophene bioisosteres of spirocyclic σ receptor ligands: Relationships between substitution pattern and σ receptor affinity | |
| CN115108986A (zh) | 阿朴菲衍生物及其制备方法和应用 | |
| EA033769B1 (ru) | ОТСЕЛЕКТИРОВАННЫЙ АМИД γ-ГИДРОКСИМАСЛЯНОЙ КИСЛОТЫ И ЕГО ПРИМЕНЕНИЯ ПРИ ЛЕЧЕНИИ ЗЛОУПОТРЕБЛЕНИЯ АЛКОГОЛЕМ | |
| JP6905988B2 (ja) | Eaat3阻害剤としてのピラゾール−ピリジン誘導体 | |
| JP6831376B2 (ja) | トリアゾール誘導体 |